BACKGROUND: The R6/1 mouse line is one of the most widely employed models of Huntington Disease (HD), a complex syndrome characterized by motor and non-motor deficits. Surprisingly, its behavioral phenotype during the early phases of the pathology when the motor impairments are not manifest yet has been poorly investigated. It is also not clear whether the expression of HD-like symptoms at the pre-motor stage in this mouse model differs between the two sexes. METHODS: Male and female 12 weeks-old R6/1 mice and their wild-type littermates were tested on a battery of tests modeling some of the major neuropsychiatric non-motor symptoms of HD: alterations in social interest, social interaction and communication, as well as disturbances in prepu...
Rationale: Huntington's disease (HD) is characterized by progressive motor dysfunction, emotional di...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
Transgenic mice expressing exon 1 of the human Huntington's disease (HD) gene carrying a 141-157 CAG...
The R6/1 mouse line is one of the most widely employed models of Huntington Disease (HD), a complex ...
Huntington's disease is caused by a single mutation on the HTT gene which produces an expansion in t...
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that affects men and w...
To determine the suitability of mouse models of disease for therapeutic trials, the models must be c...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
Rationale: Huntington's disease (HD) is characterized by progressive motor dysfunction, emotional di...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
Transgenic mice expressing exon 1 of the human Huntington's disease (HD) gene carrying a 141-157 CAG...
The R6/1 mouse line is one of the most widely employed models of Huntington Disease (HD), a complex ...
Huntington's disease is caused by a single mutation on the HTT gene which produces an expansion in t...
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that affects men and w...
To determine the suitability of mouse models of disease for therapeutic trials, the models must be c...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
Huntington's disease is caused by a single mutation resulting in an expanded polyglutamine sequence ...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
Rationale: Huntington's disease (HD) is characterized by progressive motor dysfunction, emotional di...
In Huntington disease (HD) the prodromal phase has been increasingly investigated and is currently i...
Transgenic mice expressing exon 1 of the human Huntington's disease (HD) gene carrying a 141-157 CAG...